Biggest changeConsolidated Statements of Operations and Comprehensive Loss Twelve Months Ended December 31, 2022 2021 2020 Amount % of Net Sales Amount % of Net Sales Amount % of Net Sales (Dollars in thousands) Net sales $ 595,344 100 % $ 425,489 100 % $ 318,790 100 % Cost of goods sold 409,311 69 263,343 62 185,880 58 Gross profit 186,033 31 162,146 38 132,910 42 Selling, general and administrative expenses 238,016 40 186,809 44 134,908 42 Loss from operations (51,983 ) (9 ) (24,663 ) (6 ) (1,998 ) (1 ) Other income/(expenses), net 1,710 0 13 0 87 0 Interest expense (5,208 ) (1 ) (2,882 ) (1 ) (1,212 ) (0 ) Loss before income taxes (55,481 ) (10 ) (27,532 ) (6 ) (3,123 ) (1 ) Income tax expense 282 0 162 0 65 0 Loss on equity method investment 3,731 1 2,005 0 - 0 Net loss $ (59,494 ) (10 )% $ (29,699 ) (7 )% $ (3,188 ) (1 )% 34 Twelve Months Ended December 31, 2022 Compared To Twelve Months Ended December 31, 2021 Net Sales The following table sets forth net sales by class of retail: Year Ended December 31, 2022 2021 Amount % of Net Sales Store Count Amount % of Net Sales Store Count (Dollars in thousands) Grocery (including Online), Mass and Club (1) $ 524,971 88 % 19,670 $ 356,965 84 % 18,139 Pet Specialty and Natural (2) 70,373 12 % 5,611 68,524 16 % 5,492 Net Sales (3) $ 595,344 100 % 25,281 $ 425,489 100 % 23,631 (1) Stores at December 31, 2022 and December 31, 2021 consisted of 13,847 and 12,723 grocery (including online) and 5,823 and 5,416 mass and club, respectively.
Biggest changeAt December 31, 2023, we had a full valuation allowance against our net deferred tax assets as the realization of such assets was not considered more likely than not. 28 Consolidated Statements of Operations and Comprehensive Loss Twelve Months Ended December 31, 2023 2022 2021 Amount % of Net Sales Amount % of Net Sales Amount % of Net Sales (Dollars in thousands) Net sales $ 766,895 100 % $ 595,344 100 % $ 425,489 100 % Cost of goods sold 516,023 67 409,311 69 263,343 62 Gross profit 250,872 33 186,033 31 162,146 38 Selling, general and administrative expenses 281,318 37 238,016 40 186,809 44 Loss from operations (30,446 ) (4 ) (51,983 ) (9 ) (24,663 ) (6 ) Interest and other income, net 13,029 2 1,710 0 13 0 Interest expense (14,097 ) (2 ) (5,208 ) (1 ) (2,882 ) (1 ) Loss before income taxes (31,514 ) (4 ) (55,481 ) (10 ) (27,532 ) (6 ) Income tax expense 210 0 282 0 162 0 Loss on equity method investment 1,890 0 3,731 1 2,005 0 Net loss $ (33,614 ) (4 )% $ (59,494 ) (10 )% $ (29,699 ) (7 )% Twelve Months Ended December 31, 2023 Compared To Twelve Months Ended December 31, 2022 Net Sales The following table sets forth net sales by class of retail: Year Ended December 31, 2023 2022 Amount % of Net Sales Store Count Amount % of Net Sales Store Count (Dollars in thousands) Grocery, Mass and Club (1) $ 685,307 89 % 21,135 $ 524,971 88 % 19,670 Pet Specialty and Natural (2) 81,588 11 % 5,642 70,373 12 % 5,611 Net Sales $ 766,895 100 % 26,777 $ 595,344 100 % 25,281 (1) Stores at December 31, 2023 and December 31, 2022 consisted of 14,800 and 13,847 grocery and 6,335 and 5,823 mass and club, respectively.
Our business model is difficult for others to replicate, and we see significant opportunity for future growth by leveraging the unique elements of our business, including our brand, our product know-how, our Freshpet Kitchens, our refrigerated distribution, our Freshpet Fridge and our culture.
Our business model is difficult for others to replicate, and we see significant opportunity for future growth by leveraging the unique elements of our business, including our brand, product know-how, Freshpet Kitchens, refrigerated distribution, Freshpet Fridge, and culture.
Additionally, our cash flow generation ability is subject to general economic factors, including but not limited to increasing inflation and interest rates, financial, competitive, legislative and regulatory factors and other factors that are beyond our control.
Additionally, our cash flow generation ability is subject to general economic factors, including but not limited to increasing interest rates and inflation, financial, competitive, legislative and regulatory factors and other factors that are beyond our control.
Research and development costs consist of expenses to develop and test new products. The costs are expensed as incurred. 33 Brokerage. We use third-party brokers to assist with monitoring our products at the point-of-sale as well as representing us at headquarters for various customers. These brokers visit our retail customers’ store locations to ensure items are appropriately stocked and maintained.
Research and development costs consist of expenses to develop and test new products. The costs are expensed as incurred. Brokerage. We use third-party brokers to assist with monitoring our products at the point-of-sale as well as representing us at headquarters for various customers. These brokers visit our retail customers’ store locations to ensure items are appropriately stocked and maintained.
To the extent that there are differences between our estimate and the actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. 44 The following critical accounting policies reflect significant judgments and estimates used in preparation of our consolidated financial statements: Revenue Recognition and Incentives —Revenue is reported net of applicable trade incentives and allowances.
To the extent that there are differences between our estimate and the actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. 38 The following critical accounting policies reflect significant judgments and estimates used in preparation of our consolidated financial statements: Revenue Recognition and Incentives —Revenue is reported net of applicable trade incentives and allowances.
The performance-based awards with financial criteria either have a Net Sales and/or Adjusted EBITDA target from FY 2023 through FY 2025. We recognize the estimated fair value of performance-based awards as share-based compensation expense over the performance period based upon our determination of whether it is probable that the performance targets will be achieved.
The performance-based awards with financial criteria either have a Net Sales and/or Adjusted EBITDA target from FY 2023 through FY 2026. We recognize the estimated fair value of performance-based awards as share-based compensation expense over the performance period based upon our determination of whether it is probable that the performance targets will be achieved.
Management’s Discussion and Analysis of Financial Condition and Results of Operations" in the Company's 2021 Annual Report on Form 10-K, which information is incorporated herein by reference. Overview We started Freshpet with a single-minded mission to bring the power of real, fresh food to our dogs and cats.
Management’s Discussion and Analysis of Financial Condition and Results of Operations" in the Company's 2022 Annual Report on Form 10-K, which information is incorporated herein by reference. Overview We started Freshpet with a single-minded mission to bring the power of real, fresh food to our dogs and cats.
Recent Accounting Pronouncements For a discussion of recent accounting pronouncements, see Note 1 (Summary of Significant Accounting Policies) to our audited consolidated financial statements included in this report. Segment We have determined we operate in one segment: the manufacturing, marketing and distribution of pet food and pet treats for dogs and cats. 45
Recent Accounting Pronouncements For a discussion of recent accounting pronouncements, see Note 1 (Summary of Significant Accounting Policies) to our audited consolidated financial statements included in this report. Segment We have determined we operate in one segment: the manufacturing, marketing and distribution of pet food and pet treats for dogs and cats. 39
(c) Represents COVID-19 expenses including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigating potential supply chain disruptions during the pandemic included in SG&A.
(e) Represents COVID-19 expenses including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigating potential supply chain disruptions during the pandemic included in SG&A.
Our investments in marketing and advertising help to drive awareness and trial at each point of sale. ● Increasing penetration of Freshpet Fridge locations in major classes of retail, including Grocery (including online), Mass, Club, Pet Specialty and Natural.
Our investments in marketing and advertising help to drive awareness and trial at each point of sale. ● Increasing penetration of Freshpet Fridge locations in major classes of retail, including Grocery, Mass, Club, Pet Specialty, Natural, and Digital.
For more information regarding our consolidated results and liquidity and capital resources for the year ended December 31, 2021 as compared to the year ended December 31, 2020, refer to "Part II, Item 7.
For more information regarding our consolidated results and liquidity and capital resources for the year ended December 31, 2022 as compared to the year ended December 31, 2021, refer to "Part II, Item 7.
Income Taxes We had federal net operating loss (“NOL”) carry forwards of approximately $340.3 million as of December 31, 2022, of which, approximately $175.4 million, generated in 2017 and prior, will expire between 2025 and 2037.
Income Taxes We had federal net operating loss (“NOL”) carry forwards of approximately $420.3 million as of December 31, 2023, of which, approximately $175.4 million, generated in 2017 and prior, will expire between 2025 and 2037.
The NOL generated from 2018 through 2022, of approximately $164.9 million, will have an indefinite carryforward period but can generally only be used to offset 80% of taxable income in any particular year.
The NOL generated from 2018 through 2023, of approximately $244.9 million, will have an indefinite carryforward period, but can generally only be used to offset 80% of taxable income in any particular year.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of net sales and expenses during the reporting period.
GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of net sales and expenses during the reporting period.
(d) Represents transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives. 38 The following table provides a reconciliation of Adjusted Gross Profit to Gross Profit, the most directly comparable financial measure presented in accordance with U.S.
(f) Represents a true-up to transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives. 32 The following table provides a reconciliation of Adjusted Gross Profit to Gross Profit, the most directly comparable financial measure presented in accordance with U.S.
Loss on Equity Method Investment Our loss on equity method investment for the twelve months ended December 31, 2022 was $3.7 million as compared to a loss on equity method investment of $2.0 million in the prior year from the Company's 19% interest in a privately held company, as discussed in Note 1.
Loss on Equity Method Investment Our loss on equity method investment for the twelve months ended December 31, 2023 was $1.9 million as compared to a loss on equity method investment of $3.7 million in the prior year from the Company's interest in a privately held company, as discussed in Note 1.
If we issue additional equity or convertible debt securities, existing stockholders may experience dilution, and such new securities could have rights senior to those of our common stock. These factors may make the timing, amount, terms and conditions of additional financings unattractive.
If we issue additional equity or if the Convertible Notes are converted to common shares, existing stockholders may experience dilution, and such new securities could have rights senior to those of our common stock. These factors may make the timing, amount, terms and conditions of additional financing unattractive.
We expect to fund our ongoing operations and obligations with cash and cash equivalents, cash flow from operations and available funds under our Credit Facility. 41 The following table sets forth, for the periods indicated, our beginning balance of cash, net cash flows provided by operating, investing and financing activities and our ending balance of cash.
We expect to fund our ongoing operations and obligations with cash and cash equivalents, and cash flow from operations. 35 The following table sets forth, for the periods indicated, our beginning balance of cash, net cash flows provided by operating, investing and financing activities and our ending balance of cash.
While our significant accounting estimates and policies are described in the notes to our financial statements appearing in this report, we believe that the following critical accounting estimates and policies are most important to understanding and evaluating our reported financial results.
While our significant accounting estimates and policies are described in the notes to our financial statements appearing in this report, we believe that the following critical accounting estimates and policies are most important to understanding and evaluating our reported financial results. The preparation of financial statements in conformity with U.S.
Our net sales growth is driven by the following key factors: ● Increasing sales velocity from the average Freshpet Fridge due to increasing awareness, trial and adoption of Freshpet products and innovation.
Sales are recorded net of discounts, returns and promotional allowances. Our net sales growth is driven by the following key factors: ● Increasing sales velocity from the average Freshpet Fridge due to increasing awareness, trial and adoption of Freshpet products and innovation.
For the twelve months ended December 31, 2022, Adjusted Gross Profit was $214.1 million, or 36.0% as a percentage of net sales, compared to $184.6 million, or 43.4% as a percentage of net sales, in the prior year.
For the twelve months ended December 31, 2023, Adjusted Gross Profit was $306.6 million, or 40.0% as a percentage of net sales, compared to $214.1 million, or 36.0% as a percentage of net sales, in the prior year.
The impact of new Freshpet Fridge installations on our net sales varies by retail class and depends on numerous factors including store traffic, refrigerator size, placement within the store, and proximity to other stores that carry our products. ● Consumer trends including growing pet ownership, pet humanization and a focus on health and wellness.
The impact of new Freshpet Fridge installations on our net sales varies by retail class and depends on numerous factors including store traffic, refrigerator size, placement within the store, and proximity to other stores that carry our products. ● Consumer trends including growing pet ownership, pet humanization and a focus on health and wellness. ● At times we increase our sales price to offset any adverse movement in input costs.
(c) Represents COVID-19 expenses including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigating potential supply chain disruptions during the pandemic included in SG&A.
(d) Represents COVID-19 expenses including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigating potential supply chain disruptions during the pandemic. (e) Represents advisory fees related to activism engagement.
GAAP: Twelve Months Ended December 31, 2022 2021 2020 (Dollars in thousands) Gross Profit $ 186,033 $ 162,146 $ 132,910 Depreciation expense 20,774 16,545 9,576 Non-cash share-based compensation 7,293 4,152 2,132 COVID-19 expense (a) — 1,753 3,497 Adjusted Gross Profit $ 214,100 $ 184,596 $ 148,115 Adjusted Gross Profit as a % of Net Sales 36.0 % 43.4 % 46.5 % (a) Represents COVID-19 expenses including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigating potential supply chain disruptions during the pandemic included in cost of goods sold.
GAAP: Twelve Months Ended December 31, 2023 2022 2021 (Dollars in thousands) Gross profit $ 250,872 $ 186,033 $ 162,146 Depreciation expense 41,209 20,774 16,545 Non-cash share-based compensation 10,995 7,293 4,152 COVID-19 expense (a) — — 1,753 Loss on disposal of manufacturing equipment 3,547 — — Adjusted Gross Profit $ 306,623 $ 214,100 $ 184,596 Adjusted Gross Profit as a % of Net Sales 40.0 % 36.0 % 43.4 % (a) Represents COVID-19 expenses including (i) costs incurred to protect the health and safety of our employees during the COVID-19 pandemic, (ii) temporary increased compensation expense to ensure continued operations during the pandemic, and (iii) costs related to mitigating potential supply chain disruptions during the pandemic included in cost of goods sold.
Additionally, our ability to make payments on, and to refinance, any indebtedness under our credit facilities and to fund any necessary expenditures for our growth will depend on our ability to generate cash in the future.
Our ability to make future minimum interest payments on the Convertible Notes, to refinance any indebtedness and to fund any necessary expenditures for our growth will depend on our ability to generate cash in the future.
For example, the non-GAAP financial measures do not reflect: ● our capital expenditures or future requirements for capital expenditures; ● the interest expense, or the cash requirements necessary to service interest expense or principal payments, associated with indebtedness; ● depreciation and amortization, which are non-cash charges, although the assets being depreciated and amortized will likely have to be replaced in the future, nor any cash requirements for such replacements; and ● changes in cash requirements for our working capital needs. 37 Additionally, Adjusted EBITDA excludes non-cash share-based compensation expense, which is and will remain a key element of our overall long-term incentive compensation package.
For example, the non-GAAP financial measures do not reflect: ● our capital expenditures or future requirements for capital expenditures; ● the interest expense, or the cash requirements necessary to service interest expense or principal payments, associated with indebtedness; ● depreciation and amortization, which are non-cash charges, although the assets being depreciated and amortized will likely have to be replaced in the future, nor any cash requirements for such replacements; and ● changes in cash requirements for our working capital needs.
GAAP results and the reconciliation to the closest comparable U.S. GAAP measures, provides a more complete understanding of our business than could be obtained absent this disclosure. We use the non-GAAP financial measures, together with U.S.
We believe that each of these non-GAAP financial measures provide additional metrics to evaluate our operations and, when considered with both our U.S. GAAP results and the reconciliation to the closest comparable U.S. GAAP measures, provides a more complete understanding of our business than could be obtained absent this disclosure. We use the non-GAAP financial measures, together with U.S.
The decrease was primarily due to the change in accounts receivable, inventory, accounts payable, other assets, other lease liabilities and prepaid expenses, offset by change in accrued expenses. 2021 Net cash provided by operating activities of $0.6 million in 2021 was primarily attributed to: ● $31.2 million of net income adjusted for reconciling non-cash items, which excludes $60.9 million of non-cash items primarily related to $30.5 million in depreciation and amortization, $25.0 million in share-based compensation, $2.0 million of investments in equity method investment, $1.3 million of change in operating lease right of use asset, $1.2 million of amortization of deferred financing costs, $0.5 million in loss on disposal of equipment, and $0.3 million in inventory obsolescence.
The increase was primarily due to the change in accounts receivable, accounts payable and accrued expenses, primarily offset by the change in inventories, prepaid expenses and other current assets, other assets and operating lease liability. 2022 Net cash used in operating activities of $43.2 million in 2022 was primarily attributed to: ● $10.9 million of net income adjusted for reconciling non-cash items, which excludes $70.4 million of non-cash items primarily related to $34.6 million in depreciation and amortization, $26.1 million in share-based compensation, $3.7 million of investments in equity method investment, $3.5 million in inventory obsolescence, $1.4 million of change in operating lease right of use asset, $0.8 million of amortization of deferred financing costs and $0.4 million in loss on disposal of property, plant and equipment.
Our ability to obtain additional funding will be subject to various factors, including general market conditions, our operating performance, the market’s perception of our growth potential, lender sentiment and our ability to incur additional debt in compliance with other contractual restrictions, such as financial covenants under our debt agreements, which we cannot provide assurance we will be able to do.
Our ability to obtain additional funding will be subject to various factors, including general economic and market conditions, our operating performance, the market's perception of our growth potential, lender sentiment and our ability to incur additional debt in compliance with other contractual restrictions.
The decrease was primarily due to the change in accounts receivable, inventory, other assets, prepaid expenses, other lease liabilities and accrued expenses, offset by change in accounts payable. 42 Net Cash Used in Investing Activities 2022 Net cash used in investing activities of $233.4 million in 2022 was primarily attributed to: ● $28.4 million in capital expenditures related to Freshpet Kitchens South expansion. ● $165.1 million in capital expenditures related to Freshpet Kitchens Ennis expansion. ● $27.4 million in in capital expenditures related to investment in fridges and other capital spend. ● $9.2 million in plant recurring capital expenditures. ● $19.8 million purchase of short-term investments. ● $3.3 million investment in equity method investment.
The decrease was primarily due to the change in accounts receivable, inventory, accounts payable, other assets, other lease liabilities and prepaid expenses, offset by change in accrued expenses. 36 Net Cash Used in Investing Activities 2023 Net cash used in investing activities of $239.1 million in 2023 was primarily attributed to: ● $5.3 million in capital expenditures related to Freshpet Kitchens South expansion. ● $183.5 million in capital expenditures related to Freshpet Kitchens Ennis expansion. ● $39.3 million in capital expenditures related to investment in fridges and other capital spend. ● $11.0 million in plant recurring capital expenditures. ● $113.4 million purchase of short-term investments.
This was partially offset by: ● $78.0 million for repayment of borrowings under Credit Facility ● $1.4 million for tax withholdings related to net share settlements of restricted stock units. 2021 Net cash provided by financing activities of $327.0 million in 2021 was primarily attributed to: ● $332.2 million of proceeds from common shares issued in a primary offering, net of issuance cost. ● $2.3 million of proceeds from the exercise of stock options.
This was partially offset by: ● $66.2 million for the purchase of capped call options. ● $2.0 million for debt issuance costs. ● $1.4 million for tax withholdings related to net share settlements of restricted stock units. ● $1.1 million for principal payments under finance lease obligations. 2022 Net cash provided by financing activities of $336.5 million in 2022 was primarily attributed to: ● $337.5 million of proceeds from common shares issued in a primary offering, net of issuance cost. ● $78.0 million of proceeds from borrowings under Credit Facility. ● $0.5 million of proceeds from the exercise of stock options.
The decrease in Adjusted EBITDA was a result of increased Adjusted SG&A expense (including $4.1 million of launch expense) partially offset by higher net sales and Adjusted Gross Profit (including $26.1 million of plant start-up expense). See "—Non-GAAP Financial Measures" for how we define Adjusted EBITDA, a reconciliation of Adjusted EBITDA to EBITDA, the closest comparable U.S.
The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit partially offset by higher Adjusted SG&A expense. See "—Non-GAAP Financial Measures" for how we define Adjusted EBITDA, a reconciliation of Adjusted EBITDA to EBITDA, the closest comparable U.S.
GAAP measure, certain limitations of Non-GAAP measures and why management has included such Non-GAAP measures, as well as for a discussion of certain changes we made to our methodology for calculating Adjusted EBITDA beginning with the period ending September 30, 2022; see the section entitled "Forward-Looking Statements" in this report and the section entitled "Risk Factors" in this report for factors that could cause our results to differ, in some cases materially. 36 Non-GAAP Financial Measures Freshpet uses the following non-GAAP financial measures in its financial communications.
GAAP measure, certain limitations of Non-GAAP measures and why management has included such Non-GAAP measures; see the section entitled "Forward-Looking Statements" in this report and the section entitled "Risk Factors" in this report for factors that could cause our results to differ, in some cases materially. Non-GAAP Financial Measures Freshpet uses the following non-GAAP financial measures in its financial communications.
Loss from Operations Loss from operations increased by $27.3 million to a loss from operations of $52.0 million for the twelve months ended December 31, 2022 as compared to a loss from operations of $24.7 million in the prior year as a result of the factors discussed above.
Loss from Operations As a result of the factors discussed above, loss from operations decreased by $21.5 million to a loss from operations of $30.4 million for the twelve months ended December 31, 2023 as compared to a loss from operations of $52.0 million in the prior year.
Selling, General and Administrative Expenses Our selling, general and administrative expenses consist of the following: Outbound freight. We use a third-party logistics provider for outbound freight that ships directly to retailers as well as third-party distributors. Marketing & advertising.
We expect to continue to mitigate any adverse movement in input costs through a combination of cost management and price increases. Selling, General and Administrative Expenses Our selling, general and administrative expenses consist of the following: Outbound freight. We use a third-party logistics provider for outbound freight that ships directly to retailers as well as third-party distributors. Marketing & advertising.
We believe that cash and cash equivalents, expected cash flow from operations, planned borrowing capacity and our ability to access the capital markets, if appropriate, are adequate to fund our debt service requirements, operating lease obligations, capital expenditures and working capital obligations for the foreseeable future.
We believe that cash and cash equivalents, short-term investments, expected cash flow from operations, amounts previously raised through the issuance of the Convertible Notes and our ability to access the capital markets, if appropriate, are adequate to fund our debt requirements, operating and finance lease obligations, capital expenditures and working capital obligations for the foreseeable future.
This was offset by: ● $19.8 million of proceeds from maturities of short-term investments. 2021 Net cash used in investing activities of $322.1 million in 2021 was primarily attributed to: ● $3.0 million in capital expenditures related to Freshpet Kitchens Bethlehem expansion. ● $73.8 million in capital expenditures related to Freshpet Kitchens South expansion. ● $208.2 million in capital expenditures related to Freshpet Kitchens Ennis expansion. ● $16.8 million in plant recurring capital expenditures. ● $20.3 million in capital expenditures relating to investment in fridges and other capital spend.
This was partially offset by: ● $113.4 million of proceeds from maturities of short-term investments. 2022 Net cash used in investing activities of $233.4 million in 2022 was primarily attributed to: ● $28.4 million in capital expenditures related to Freshpet Kitchens South expansion. ● $165.1 million in capital expenditures related to Freshpet Kitchens Ennis expansion. ● $27.4 million in capital expenditures related to investment in fridges and other capital spend. ● $9.2 million in plant recurring capital expenditures. ● $19.8 million purchase of short-term investments. ● $3.3 million investment in equity method investment.
This was partially offset by: ● $4.2 million for tax withholdings related to net share settlements of restricted stock units. ● $3.3 million for debt issuance cost related to the new credit facilities. 43 Indebtedness For a discussion of our material indebtedness, see Note 6 to our Consolidated Financial Statements included in this report.
This was partially offset by: ● $78.0 million for repayment of borrowings under Credit Facility. ● $1.4 million for tax withholdings related to net share settlements of restricted stock units. 37 Indebtedness For a discussion of our material indebtedness, see Note 6 and 7 to our Consolidated Financial Statements included in this report.
GAAP. We define Adjusted Gross Profit as Gross Profit before depreciation expense, non-cash share-based compensation and COVID-19 expenses.
GAAP. We define Adjusted Gross Profit as Gross Profit before depreciation expense, non-cash share-based compensation, and loss on disposal of manufacturing equipment.
Year Ended December 31, 2022 2021 (Dollars in thousands) Cash at the beginning of period $ 72,788 $ 67,247 Net cash (used in) provided by operating activities (43,227 ) 647 Net cash used in investing activities (233,364 ) (322,099 ) Net cash provided by financing activities 336,538 326,993 Cash at the end of period $ 132,735 $ 72,788 Net C ash (Used In) Provided by Operating Activities Cash (used in) provided by operating activities consists primarily of net loss adjusted for certain non-cash items (i.e., provision for loss on receivables, loss/(gain) on disposal of equipment, change in reserve for inventory obsolescence, depreciation and amortization, amortization of deferred financing costs and loan discount, change in operating lease right of use asset, loss on equity method investment, and share-based compensation). 2022 Net cash used in operating activities of $43.2 million in 2022 was primarily attributed to: ● $10.9 million of net income adjusted for reconciling non-cash items, which excludes $70.4 million of non-cash items primarily related to $34.6 million in depreciation and amortization, $26.1 million in share-based compensation, $3.7 million of investments in equity method investment, $3.5 million in inventory obsolescence, $1.4 million of change in operating lease right of use asset, $0.8 million of amortization of deferred financing costs and $0.4 million in loss on disposal of equipment.
Year Ended December 31, 2023 2022 (Dollars in thousands) Cash at the beginning of period $ 132,735 $ 72,788 Net cash provided by (used in) operating activities 75,940 (43,227 ) Net cash used in investing activities (239,093 ) (233,364 ) Net cash provided by financing activities 327,289 336,538 Cash at the end of period $ 296,871 $ 132,735 Net Cash Provided by (Used In) Operating Activities Cash provided by (used in) operating activities consists primarily of net loss adjusted for certain non-cash items (i.e., provision for (gains) loss on receivable, loss on disposal of property, plant and equipment, share-based compensation, change in reserve for inventory obsolescence, depreciation and amortization, write-off and amortization of deferred financing costs and loan discount, change in operating lease right of use asset and loss on equity method investment). 2023 Net cash provided by operating activities of $75.9 million in 2023 was primarily attributed to: ● $61.7 million of net income adjusted for reconciling non-cash items, which excludes $95.3 million of non-cash items primarily related to $4.3 million of loss on disposal of property, plant and equipment, $24.9 million of share-based compensation including amortization of warrants, $58.5 million of depreciation and amortization, $4.1 million of write-off and amortization of deferred financing costs and loan discount, $1.5 million of change in operating lease right of use asset and $1.9 million of loss on equity method investment. ● $14.3 million increase due to changes in operating assets and liabilities.
Our presentation of the non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items. We recognize that the non-GAAP financial measures have limitations as analytical financial measures.
Our non-GAAP financial measures may not be comparable to similarly titled measures in other organizations because other organizations may not calculate non-GAAP financial measures in the same manner as we do. 31 Our presentation of the non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items.
We define Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, fees related to equity offerings of our common stock, implementation and other costs associated with the implementation of an ERP system, loss on disposal of equipment, COVID-19 expenses, and organization changes designed to support long-term growth objectives.
We define Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, implementation and other costs associated with the implementation of an ERP system, fees related to the Capped Call Transactions, loss on disposal of equipment, and advisory fees related to activism engagement.
Working capital increased $81.0 million to $172.4 million at December 31, 2022 compared with working capital of $91.4 million at December 31, 2021.
Working capital increased $165.7 million to $338.1 million at December 31, 2023 compared with working capital of $172.4 million at December 31, 2022.
Gross Profit Gross profit was $186.0 million, or 31.2% as a percentage of net sales, for the twelve months ended December 31, 2022, compared to $162.1 million, or 38.1% as a percentage of net sales, in the prior year.
The net sales increase was primarily driven by volume gains of 20%. 29 Gross Profit Gross profit was $250.9 million, or 32.7% as a percentage of net sales, for the twelve months ended December 31, 2023, compared to $186.0 million, or 31.2% as a percentage of net sales, in the prior year.
GAAP: Twelve Months Ended December 31, 2022 2021 2020 (Dollars in thousands) Net loss $ (59,494 ) $ (29,699 ) $ (3,188 ) Depreciation and amortization 34,555 30,468 21,125 Interest expense 5,208 2,882 1,211 Income tax expense 282 162 65 EBITDA $ (19,449 ) $ 3,813 $ 19,213 Loss on equity method investment $ 3,731 $ 2,005 $ - Loss on disposal of equipment 396 1,000 1,805 Non-cash share-based compensation 26,092 24,998 10,925 Equity offering expenses (a) — — 58 Enterprise Resource Planning (b) 8,558 1,379 1,682 COVID-19 expense (c) — 1,758 3,854 Organization changes (d) 734 — — Adjusted EBITDA $ 20,062 $ 34,953 $ 37,537 Adjusted EBITDA as a % of Net Sales 3.4 % 8.2 % 11.8 % (a) Represents fees associated with public offerings of our common stock.
GAAP: Twelve Months Ended December 31, 2023 2022 2021 (Dollars in thousands) Net loss $ (33,614 ) $ (59,494 ) $ (29,699 ) Depreciation and amortization 57,058 34,555 30,468 Interest expense, net of interest income 1,069 5,208 2,882 Income tax expense 210 282 162 EBITDA $ 24,723 $ (19,449 ) $ 3,813 Loss on equity method investment $ 1,890 $ 3,731 $ 2,005 Loss on disposal of property, plant and equipment 4,321 396 1,000 Non-cash share-based compensation (a) 24,936 26,092 24,998 Enterprise Resource Planning (b) 2,457 8,558 1,379 Capped Call Transaction fees (c) 113 — — COVID-19 expense (d) — — 1,758 Activism engagement (e) 8,177 — — Organization changes (f) (67 ) 734 — Adjusted EBITDA $ 66,550 $ 20,062 $ 34,953 Adjusted EBITDA as a % of Net Sales 8.7 % 3.4 % 8.2 % (a) Includes the true-up of share-based compensation expense during the period ended December 31, 2023.
To meet our capital needs, we expect to rely on our current and future cash flow from operations, our available borrowing capacity, and access to the capital markets, if appropriate.
We expect to rely on our current and future cash flow from operations, may issue additional debt, and/or raise capital through our access to capital markets, if appropriate.
GAAP: Twelve Months Ended December 31, 2022 2021 2020 (Dollars in thousands) SG&A expenses $ 238,016 $ 186,809 $ 134,908 Depreciation and amortization expense 13,781 13,923 11,549 Non-cash share-based compensation 18,799 20,846 8,793 Loss on disposal of equipment 396 1,000 1,805 Equity offering expenses (a) — — 58 Enterprise Resource Planning (b) 8,558 1,379 1,682 COVID-19 expense (c) — 5 357 Organization changes (d) 734 — — Adjusted SG&A Expenses $ 195,748 $ 149,656 $ 110,664 Adjusted SG&A Expenses as a % of Net Sales 32.9 % 35.2 % 34.7 % (a) Represents fees associated with public offerings of our common stock.
GAAP: Twelve Months Ended December 31, 2023 2022 2021 (Dollars in thousands) SG&A expenses $ 281,318 $ 238,016 $ 186,809 Depreciation and amortization expense 15,849 13,781 13,923 Non-cash share-based compensation (a) 13,941 18,799 20,846 Loss on disposal of equipment 774 396 1,000 Enterprise Resource Planning (b) 2,457 8,558 1,379 Capped Call Transactions fees (c) 113 — — Activism engagement (d) 8,177 — — COVID-19 expense (e) — — 5 Organization changes (f) (67 ) 734 — Adjusted SG&A Expenses $ 240,074 $ 195,748 $ 149,656 Adjusted SG&A Expenses as a % of Net Sales 31.3 % 32.9 % 35.2 % (a) Includes the true-up of share-based compensation expense during the period ended December 31, 2023.
The following table provides a reconciliation of EBITDA and Adjusted EBITDA to net loss, the most directly comparable financial measure presented in accordance with U.S.
Other companies in our industry may calculate the non-GAAP financial measures differently than we do, limiting their usefulness as comparative measures. The following table provides a reconciliation of EBITDA and Adjusted EBITDA to net loss, the most directly comparable financial measure presented in accordance with U.S.
Adjusted EBITDA represents EBITDA plus loss on equity method investment, non-cash share-based compensation, fees related to equity offerings of our common stock, implementation and other costs associated with the implementation of an ERP system, loss on disposal of equipment, COVID-19 expenses, and organization changes designed to support long-term growth objectives.
Adjusted EBITDA represents EBITDA plus loss on equity method investment, non-cash share-based compensation, implementation and other costs associated with the implementation of an ERP system, loss on disposal of property, plant and equipment, fees related to the Capped Call Transactions, and advisory fees related to activism engagement.
Adjusted SG&A for the twelve months ended December 31, 2022, was $195.7 million, or 32.9% as a percentage of net sales, compared to $149.7 million, or 35.2% as a percentage of net sales, in the prior year.
Adjusted SG&A for the twelve months ended December 31, 2023, was $240.1 million, or 31.3% as a percentage of net sales, compared to $195.7 million, or 32.9% as a percentage of net sales, in the prior year. See “—Non-GAAP Financial Measures” for how we define Adjusted SG&A, a reconciliation of Adjusted SG&A to SG&A, the closest comparable U.S.
Gross Profit Our gross profit is net of costs of goods sold, which include the costs of product manufacturing, product ingredients, packaging materials and inbound freight, as well as depreciation and amortization and non-cash share-based compensation. We expect to continue to mitigate any adverse movement in input costs through a combination of cost management and price increases.
We believe that as a result of the above key factors, we will continue to penetrate the pet food marketplace and increase our share of the pet food category. 27 Gross Profit Our gross profit is net of costs of goods sold, which include the costs of product manufacturing, product ingredients, packaging materials and inbound freight, as well as depreciation and amortization and non-cash share-based compensation.
During fiscal year 2022, we spent approximately $230.1 million of capital to meet our capacity needs as well as recurring capital expenditures. In fiscal year 2023, we expect to spend approximately $240.0 million.
We expect to make future capital expenditures in connection with the completion of our planned development of Freshpet Kitchens Ennis phase 2 and 3. During fiscal year 2023, we spent approximately $239.1 million of capital to meet our capacity needs as well as recurring capital expenditures. In fiscal year 2024, we expect to spend approximately $210.0 million.
The increase was partially offset by an increase in accounts payable of $12.5 million as a result of timing and capital expenditures of approximately $38.0 million related to our capital expansion plan, and an increase in accrued expenses of $18.1 million as a result of timing and capital expenditures of approximately $6.2 million related to our capital expansion plan.
The increase was partially offset by a decrease in accounts receivable of $0.8 million, a decrease in prepaid expenses of $2.2 million, a decrease in other current assets of $0.7 million, an increase in accrued expenses of $16.8 million due to timing and capital expenditures of approximately $3.8 million related to our capital expansion plan, and an increase in current finance lease liabilities of $2.0 million.
As a percentage of net sales, SG&A decreased to 40.0% for the twelve months ended December 31, 2022, compared to 43.9% in the prior year. The decrease of 390 basis points in SG&A as a percentage of net sales was mainly a result of increased selling, general and administrative expense leverage as the business scales.
Selling, General and Administrative Expenses Selling, general and administrative expenses ("SG&A") were $281.3 million, for the twelve months ended December 31, 2023, compared to $238.0 million in the prior year. As a percentage of net sales, SG&A decreased to 36.7% for the twelve months ended December 31, 2023, compared to 40.0% in the prior year.
Our credit facilities reflect $2.0 million reserved for two letters of credit and the remaining availability after 2022 borrowing activity of $78.0 million under the Delayed Draw Facility. For the year ended December 31, 2021, our capital resources consisted primarily of $72.8 million cash on hand, $348.0 million available under our $350.0 million credit facilities, subject to debt covenants.
Our credit facilities reflected $2.0 million reserved for two letters of credit and the remaining availability after the 2022 borrowing activity of $78.0 million under the Delayed Draw Facility.
Our products are sold to consumers through a fast-growing network of company-owned branded refrigerators, known as Freshpet Fridges, located in our customers’ stores. We continue to roll out Freshpet Fridges at leading retailers across North America and parts of Europe and have installed Freshpet Fridges in approximately 25,281 retail stores as of December 31, 2022.
We continue to roll out Freshpet Fridges at leading retailers across North America and parts of Europe and have installed Freshpet Fridges in approximately 26,777 retail stores as of December 31, 2023. Our products are sold under the Freshpet brand name with ingredients, packaging and labeling customized by class of retail.
The decrease in gross profit as a percentage of net sales was primarily due to increased plant start-up cost, inflation of ingredient cost and labor, and quality issues, partially offset by increased pricing, leverage on depreciation cost and prior year COVID-19 expenses.
The increase in gross profit as a percentage of net sales was primarily due to improved leverage on plant expenses, reduced quality costs, and decreased input cost as a percentage of sales mainly due to an increase in net sales pricing, partially offset by increased depreciation expense associated with the Company's capacity expansion and cost related to the disposal of equipment.
See Note 6 for additional details. 40 The following table sets forth, for the periods indicated, our working capital: December 31, December 31, 2022 2021 (Dollars in thousands) Cash and cash equivalents $ 132,735 $ 72,788 Accounts receivable, net of allowance for doubtful accounts 57,572 34,780 Inventories, net 58,290 35,574 Prepaid expenses 9,778 5,834 Other current assets 3,590 1,349 Accounts payable (55,088 ) (42,612 ) Accrued expenses (33,016 ) (14,950 ) Current operating lease liabilities (1,510 ) (1,384 ) Total Working Capital $ 172,351 $ 91,379 Working capital consists of current assets net of current liabilities.
Our inability to raise capital could impede our growth or otherwise require us to forego growth opportunities and could materially adversely affect our business, financial condition and results of operations. 34 The following table sets forth, for the periods indicated, our working capital: December 31, December 31, 2023 2022 (Dollars in thousands) Cash and cash equivalents $ 296,871 $ 132,735 Accounts receivable, net of allowance for doubtful accounts 56,754 57,572 Inventories, net 63,238 58,290 Prepaid expenses 7,615 9,778 Other current assets 2,841 3,590 Accounts payable (36,096 ) (55,088 ) Accrued expenses (49,816 ) (33,016 ) Current operating lease liabilities (1,312 ) (1,510 ) Current finance lease liabilities (1,998 ) - Total Working Capital $ 338,097 $ 172,351 Working capital consists of current assets net of current liabilities.
Interest Expense Interest expense relating to our Credit Facility increased $2.3 million to interest expense of $5.2 million for the twelve months ended December 31, 2022 as compared to an interest expense of $2.9 million for the prior year as a result of the Sixth Amendment and additional borrowings discussed in Note 6.
Interest Expense Interest expense increased $8.9 million to interest expense of $14.1 million for the twelve months ended December 31, 2023 as compared to interest expense of $5.2 million for the same period in the prior year.
Adjusted EBITDA Adjusted EBITDA was $20.1 million, or 3.4% as a percentage of net sales (also called Adjusted EBITDA Margin), for the twelve months ended December 31, 2022, compared to $35.0 million, or 8.2% as a percentage of net sales, in the prior year.
Net Loss Net loss decreased $25.9 million to a net loss of $33.6 million for the twelve months ended December 31, 2023 as compared to a net loss of $59.5 million for the prior year due to contribution from higher sales, increased gross margin and reduced logistics costs as a percentage of net sales, partially offset by increased SG&A including increased media spend of $23.1 million. 30 Adjusted EBITDA Adjusted EBITDA was $66.6 million, or 8.7% as a percentage of net sales (also called Adjusted EBITDA Margin), for the twelve months ended December 31, 2023, compared to $20.1 million, or 3.4% as a percentage of net sales, in the prior year.
As of the fourth quarter of 2021, all remaining COVID-19 expenses are part of our operating performance. EBITDA represents net income (loss) plus interest expense, income tax expense and depreciation and amortization.
EBITDA represents net income (loss) plus interest expense net of interest income, income tax expense and depreciation and amortization.
Net sales increased $169.9 million, or 39.9%, to $595.3 million for the twelve months ended December 31, 2022 as compared to the prior year. The $169.9 million increase in net sales was driven by growth in the Grocery (including Online), Mass, and Club refrigerated channel of $168.0 million, with the remaining growth in Pet Specialty and Natural.
The $171.6 million increase in net sales was driven by growth in the Grocery, Mass, and Club channel of $160.3 million, with the remaining growth in Pet Specialty and Natural.
(b) Represents implementation, amortization of deferred implementation costs and other costs associated with the implementation of an ERP system.
When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed. (b) Represents implementation, amortization of deferred implementation costs and other costs associated with the implementation of an ERP system. (c) Represents fees associated with the Capped Call Transactions.
The decrease in adjusted gross profit as a percentage of net sales was primarily due to increased plant start-up cost, inflation of ingredient cost and labor, and quality issues, partially offset by increased pricing. See "—Non-GAAP Financial Measures" for how we define Adjusted Gross Profit, a reconciliation of Adjusted Gross Profit to gross profit, the closest comparable U.S.
See "—Non-GAAP Financial Measures" for how we define Adjusted Gross Profit, a reconciliation of Adjusted Gross Profit to gross profit, the closest comparable U.S. GAAP measure, certain limitations of Non-GAAP measures and why management has included such Non-GAAP measures.
We normally carry three to four weeks of finished goods inventory. As of December 31, 2022, the average duration of our accounts receivable is approximately 32 days.
We normally carry three to four weeks of finished goods inventory and less than 30 days of accounts receivable. For the year ended December 31, 2023 our capital resources consisted primarily of $296.9 million of cash and cash equivalents on hand.
The increase was primarily a result of an increase of $59.9 million in cash and cash equivalents as a result of our April 2022 primary offering as we fund our capital expansion plan, an increase in accounts receivable of $22.8 million due to increased sales, an increase in inventory of $22.7 million, and an increase in prepaid expenses of $3.9 million.
The increase was primarily a result of an increase of $164.1 million in cash and cash equivalents primarily resulting from the sale of the Convertible Notes as we fund our capital expansion plan, an increase in inventory of $4.9 million, a decrease in accounts payable of $19.0 million as a result of timing and capital expenditures of approximately $15.5 million related to our capital expansion plan and a decrease in current operating lease liabilities of $0.2 million.
Net Cash Provided by Financing Activities 2022 Net cash provided by financing activities of $336.5 million in 2022 was primarily attributed to: ● $337.5 million of proceeds from common shares issued in a primary offering, net of issuance cost. ● $78.0 million of proceeds from borrowings under Credit Facility. ● $0.5 million of proceeds from the exercise of stock options.
This was partially offset by: ● $19.8 million of proceeds from maturities of short-term investments. Net Cash Provided by Financing Activities 2023 Net cash provided by financing activities of $327.3 million in 2023 was primarily attributed to: ● $393.5 million net proceeds from Convertible Notes. ● $4.5 million cash proceeds from the exercise of stock options.
(d) Represents transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives. 39 Liquidity and Capital Resources We expect to make future capital expenditures in connection with the completion of our planned development and of Freshpet Kitchens Ennis Phase 1, Ennis Phase 2, Ennis Chicken Processing and Freshpet Kitchens South.
(f) Represents a true-up to transition costs related to the organization changes designed to support growth, including several changes in organizational structure designed to enhance capabilities and support long-term growth objectives. 33 Liquidity and Capital Resources To meet our capital needs, we issued approximately $402.5 million in convertible notes in March 2023 (the "Convertible Notes"), used $66.2 million of the proceeds to enter into capped call transactions, and used $11.0 million of the proceeds on debt issuance related costs.
(b) Represents implementation, amortization of deferred implementation costs and other costs associated with the implementation of an ERP system.
When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed. (b) Represents implementation, amortization of deferred implementation costs and other costs associated with the implementation of an ERP system. (c) Represents fees associated with the Capped Call Transactions. (d) Represents advisory fees related to activism engagement.
At December 31, 2022, we had approximately $259.4 million of state NOLs, which expire between 2023 and 2041, and had $14.3 million of foreign NOLs which do not expire. At December 31, 2022, we had a full valuation allowance against our net deferred tax assets as the realization of such assets was not considered more likely than not.
At December 31, 2023, we had approximately $312.8 million of state NOLs, which expire between 2024 and 2043, and had $20.7 million of foreign NOLs in the United Kingdom which do not expire.
Net Loss Net loss increased $29.8 million to a net loss of $59.5 million for the twelve months ended December 31, 2022 as compared to a net loss of $29.7 million for the prior year due to increased SG&A, which includes increased media spend of $16.6 million and increased plant start-up cost of $21.2 million, partially offset by higher net sales and increased gross profit.
(2) Stores at December 31, 2023 and December 31, 2022 consisted of 5,164 and 5,135 pet specialty and 478 and 476 natural, respectively. Net sales increased $171.6 million, or 28.8%, to $766.9 million for the twelve months ended December 31, 2023 as compared to the prior year.